On the Board | GenomeWeb

On the Board

Some 40 percent of the largest pharmaceutical companies have at least one board member on their board of directors who is also in a leadership position at an academic medical center, researchers led by Walid Gellad from the VA Pittsburgh Healthcare System and his colleagues report in the Journal of the American Medical Association this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Some Ties Questioned

Disappearing Postdocs

Still a Gap

The Ties

The Scores' Effect

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.